Polynoma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Polynoma General Information

Description

Developer of an immuno-oncology vaccine focused on the treatment of melanoma. The company's oncology-focused biotechnology offers antigen vaccines which include a novel, polyvalent antigen vaccine, multicenter, double- blind seviprotimut-L.

Contact Information

Formerly Known As
Polynoma Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11230 Sorrento Valley Road
  • Suite 215
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 11230 Sorrento Valley Road
  • Suite 215
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polynoma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Polynoma‘s full profile, request access.

Request a free trial

Polynoma Patents

Polynoma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016168361-A1 Polyvalent vaccines and combination therapy for the treatment of melanoma Inactive 14-Apr-2015

Polynoma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Polynoma‘s full profile, request access.

Request a free trial

Polynoma FAQs

  • When was Polynoma founded?

    Polynoma was founded in 2007.

  • Where is Polynoma headquartered?

    Polynoma is headquartered in San Diego, CA.

  • What industry is Polynoma in?

    Polynoma’s primary industry is Drug Discovery.

  • Is Polynoma a private or public company?

    Polynoma is a Private company.

  • What is Polynoma’s current revenue?

    The current revenue for Polynoma is .

  • Who are Polynoma’s investors?

    CK Life Sciences Int'l., (Holdings) has invested in Polynoma.

  • When was Polynoma acquired?

    Polynoma was acquired on 08-Oct-2025.

  • Who acquired Polynoma?

    Polynoma was acquired by TransCode Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process